The BCL6 proto‐oncogene is a key effector of FoxO in self‐renewing signaling in CML‐initiating cells and inhibits Arf and p53 in CML cells. Here, CDKN2A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.